BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 28031478)

  • 1. TRIM65-catalized ubiquitination is essential for MDA5-mediated antiviral innate immunity.
    Lang X; Tang T; Jin T; Ding C; Zhou R; Jiang W
    J Exp Med; 2017 Feb; 214(2):459-473. PubMed ID: 28031478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM13 is a negative regulator of MDA5-mediated type I interferon production.
    Narayan K; Waggoner L; Pham ST; Hendricks GL; Waggoner SN; Conlon J; Wang JP; Fitzgerald KA; Kang J
    J Virol; 2014 Sep; 88(18):10748-57. PubMed ID: 25008915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DHX29 functions as an RNA co-sensor for MDA5-mediated EMCV-specific antiviral immunity.
    Zhu Q; Tan P; Li Y; Lin M; Li C; Mao J; Cui J; Zhao W; Wang HY; Wang RF
    PLoS Pathog; 2018 Feb; 14(2):e1006886. PubMed ID: 29462185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encephalomyocarditis Virus Abrogates the Interferon Beta Signaling Pathway via Its Structural Protein VP2.
    Han Y; Xie J; Xu S; Bi Y; Li X; Zhang H; Idris A; Bai J; Feng R
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33328314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZFYVE1 negatively regulates MDA5- but not RIG-I-mediated innate antiviral response.
    Zhong X; Feng L; Zang R; Lei CQ; Yang Q; Shu HB
    PLoS Pathog; 2020 Apr; 16(4):e1008457. PubMed ID: 32251420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A RIG-I-like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination.
    Min YQ; Ning YJ; Wang H; Deng F
    J Biol Chem; 2020 Jul; 295(28):9691-9711. PubMed ID: 32471869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The E3 Ubiquitin Ligase TRIM40 Attenuates Antiviral Immune Responses by Targeting MDA5 and RIG-I.
    Zhao C; Jia M; Song H; Yu Z; Wang W; Li Q; Zhang L; Zhao W; Cao X
    Cell Rep; 2017 Nov; 21(6):1613-1623. PubMed ID: 29117565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PACT is required for MDA5-mediated immunoresponses triggered by Cardiovirus infection via interaction with LGP2.
    Miyamoto M; Komuro A
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):227-233. PubMed ID: 29032202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of MDA5-MAVS Antiviral Signaling Axis by TRIM25 through TRAF6-Mediated NF-κB Activation.
    Lee NR; Kim HI; Choi MS; Yi CM; Inn KS
    Mol Cells; 2015 Sep; 38(9):759-64. PubMed ID: 26299329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PACT Facilitates RNA-Induced Activation of MDA5 by Promoting MDA5 Oligomerization.
    Lui PY; Wong LR; Ho TH; Au SWN; Chan CP; Kok KH; Jin DY
    J Immunol; 2017 Sep; 199(5):1846-1855. PubMed ID: 28760879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP18 positively regulates innate antiviral immunity by promoting K63-linked polyubiquitination of MAVS.
    Hou J; Han L; Zhao Z; Liu H; Zhang L; Ma C; Yi F; Liu B; Zheng Y; Gao C
    Nat Commun; 2021 May; 12(1):2970. PubMed ID: 34016972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM9 promotes type I interferon-mediated innate immunity during encephalomyocarditis virus infection.
    Bazzone LE; Zhu J; King M; Liu G; Guo Z; MacKay CR; Kyawe PP; Qaisar N; Rojas-Quintero J; Owen CA; Brass AL; McDougall W; Baer CE; Cashman T; Trivedi CM; Gack MU; Finberg RW; Kurt-Jones EA
    Nat Commun; 2024 May; 15(1):4153. PubMed ID: 38755212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOIL1 Is Essential for the Induction of Type I and III Interferons by MDA5 and Regulates Persistent Murine Norovirus Infection.
    MacDuff DA; Baldridge MT; Qaqish AM; Nice TJ; Darbandi AD; Hartley VL; Peterson ST; Miner JJ; Iwai K; Virgin HW
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARRDC4 regulates enterovirus 71-induced innate immune response by promoting K63 polyubiquitination of MDA5 through TRIM65.
    Meng J; Yao Z; He Y; Zhang R; Zhang Y; Yao X; Yang H; Chen L; Zhang Z; Zhang H; Bao X; Hu G; Wu T; Cheng J
    Cell Death Dis; 2017 Jun; 8(6):e2866. PubMed ID: 28594402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses.
    Venkataraman T; Valdes M; Elsby R; Kakuta S; Caceres G; Saijo S; Iwakura Y; Barber GN
    J Immunol; 2007 May; 178(10):6444-55. PubMed ID: 17475874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small self-RNA generated by RNase L amplifies antiviral innate immunity.
    Malathi K; Dong B; Gale M; Silverman RH
    Nature; 2007 Aug; 448(7155):816-9. PubMed ID: 17653195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response.
    Jiang X; Kinch LN; Brautigam CA; Chen X; Du F; Grishin NV; Chen ZJ
    Immunity; 2012 Jun; 36(6):959-73. PubMed ID: 22705106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Hemoglobin Subunit Beta Functions as a Pleiotropic Regulator of RIG-I/MDA5-Mediated Antiviral Innate Immune Responses.
    Yang Q; Bai SY; Li LF; Li S; Zhang Y; Munir M; Qiu HJ
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31167908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epigenetic modifier PBRM1 restricts the basal activity of the innate immune system by repressing retinoic acid-inducible gene-I-like receptor signalling and is a potential prognostic biomarker for colon cancer.
    Shu XS; Zhao Y; Sun Y; Zhong L; Cheng Y; Zhang Y; Ning K; Tao Q; Wang Y; Ying Y
    J Pathol; 2018 Jan; 244(1):36-48. PubMed ID: 28940253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Noncoding RNA ITPRIP-1 Positively Regulates the Innate Immune Response through Promotion of Oligomerization and Activation of MDA5.
    Xie Q; Chen S; Tian R; Huang X; Deng R; Xue B; Qin Y; Xu Y; Wang J; Guo M; Chen J; Tang S; Li G; Zhu H
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.